← Back to Search

Navigation for Research Awareness (AWEI Trial)

N/A
Waitlist Available
Led By Michelle Y Marttin, PhD
Research Sponsored by University of Tennessee
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 3 months of receiving intervention
Awards & highlights

AWEI Trial Summary

This trial is testing whether increasing awareness about clinical research will make African American cancer survivors more likely to participate, so recruitment efforts can be more effective.

AWEI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 3 months of receiving intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 3 months of receiving intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
recruitment yield
Secondary outcome measures
Interest in Participating in the AMPLIFI Study

AWEI Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: NavigationExperimental Treatment4 Interventions
After receiving recruitment letter from AMPLIFI, participant randomized to this arm will receive a phone call from a Research Specialist who will discuss the importance of research participation for cancer survivors to increase research awareness and aid in recruitment. The information will focus on the importance of research and will be delivered from the perspective of either a researcher or a cancer survivor.
Group II: BrochureExperimental Treatment4 Interventions
After receiving recruitment letter from AMPLIFI, participant randomized to this arm will receive a brochure which will focus on the importance of research participation for cancer survivors in order to increase research awareness and aid in recruitment.
Group III: Control GroupActive Control1 Intervention
This group will receive no intervention before receiving the AMPLIFI Recruitment Call

Find a Location

Who is running the clinical trial?

University of TennesseeLead Sponsor
188 Previous Clinical Trials
139,641 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,931,667 Total Patients Enrolled
University of Alabama at BirminghamOTHER
1,583 Previous Clinical Trials
2,278,044 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial currently in progress?

"Affirmative. The details hosted on clinicaltrials.gov confirm that this research project, which was first publicised on April 12th 2021, is actively recruiting volunteers. Approximately 2000 participants are needed for the trial between 2 different sites."

Answered by AI

How many participants are currently being recruited for this investigation?

"Affirmative. Clinicaltrials.gov reports that this clinical study, which was first published on April 12th 2021 is still open for recruitment. Approximately 2000 patients need to be recruited from two separate medical facilities."

Answered by AI
Recent research and studies
Advances in TherapyJournal
The Effectiveness of an Educational Brochure as a Risk Minimization Activity to Communicate Important Rare Adverse Events to Health-care Professionals
Bester, Nicolette, Michelle Di Vito-Smith, Theresa McGarry, Michael Riffkin, Stefan Kaehler, Richard Pilot, and Robert Bwire. 2016. “The Effectiveness of an Educational Brochure as a Risk Minimization Activity to Communicate Important Rare Adverse Events to Health-care Professionals”. Advances in Therapy. Springer Science and Business Media LLC. doi:10.1007/s12325-016-0284-y.
PsycEXTRA DatasetJournal
Knowledge and Access to Information on Recruitment of Underrepresented Populations to Cancer Clinical Trials: Evidence Report/technology Assessment, Number 122
Ford, Jean G., Johns Hopkins University Evidence-based Practice Center; Johns Hopkins University Bloomberg School of Public Health, Mollie W. Howerton, Shari Bolen, Tiffany L. Gary, Gabriel Y. Lai, Jon Tilburt, et al.. 2005. “Knowledge and Access to Information on Recruitment of Underrepresented Populations to Cancer Clinical Trials: Evidence Report/technology Assessment, Number 122”. Psycextra Dataset. American Psychological Association (APA). doi:10.1037/e439572005-001.
JNCI: Journal of the National Cancer InstituteJournal
Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20–49 Years
Ward, Elizabeth M, Recinda L Sherman, S Jane Henley, Ahmedin Jemal, David A Siegel, Eric J Feuer, Albert U Firth, et al.. 2019. “Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20–49 Years”. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP). doi:10.1093/jnci/djz106.
Journal of Community GeneticsJournal
Factors Associated with Willingness to Provide Biospecimens for Genetics Research Among African American Cancer Survivors
Ewing, Altovise T., Nnenna Kalu, Gloria Cain, Lori H. Erby, Luisel J. Ricks-Santi, Eva Tetteyfio-Kidd Telemaque, and Denise M. Scott. 2019. “Factors Associated with Willingness to Provide Biospecimens for Genetics Research Among African American Cancer Survivors”. Journal of Community Genetics. Springer Science and Business Media LLC. doi:10.1007/s12687-019-00411-0.
~500 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top